| Old Articles: <Older 771-780 Newer> |
|---|
 |
Bio-IT World
August 2005 |
Best Practices 2005 Winners Winners of the Best Practices awards include an innovative drug safety monitoring system, an integrated genomics gateway, and a genotyping pipeline.   |
Bio-IT World
August 2005
Mark D. Uehling |
GlaxoSmithKline's Safety Dashboard GlaxoSmithKline connected its global safety database with new software to manage and analyze adverse events -- and won the 2005 Best Practices Award for clinical technology. |
Bio-IT World
August 2005
Steven Withrow |
Harvard's Personalized Medicine Gateway With the right tools -- an enterprise-level, integrated infrastructure, for example -- an IT department can accelerate genetic and genomic science from discovery through clinical care. |
Bio-IT World
August 2005
Maureen McDonough |
U.K. Framework Offers Stem Cells a Future The United Kingdom has managed to cut through the noise surrounding stem cell research, creating a regulatory framework that fosters an environment of international collaboration and excellent R&D programs. And they try to do it all in an ethical way. |
Bio-IT World
August 2005
John Russell |
Pfizer's Model of Success Pfizer Global Research & Development began using sophisticated modeling technology and collaboration software to speed its race to a go-no-go decision on a cholesterol-lowering drug project. Killing the project sooner saved up to $2.8 million in costs and six months in delay. |
Bio-IT World
August 2005 |
Project Summaries Summaries of candidates for Bio-IT World's "Best Practices 2005" projects. |
Bio-IT World
August 2005
Johan Bostrom |
Agilent Acquisitions Bolster Portfolio of Products A string of acquisitions is helping Agilent Technologies establish itself as a major player in informatics for analytical laboratories, and its expanding product portfolio has made it a serious player in laboratory analysis automation and software integration. |
Bio-IT World
August 2005
G. Steven Burrill |
Biotech Outperforms Market in Q2 Heading into the summer, biotech widely outperformed the Dow and Nasdaq on a year-to-date basis. But the positive performance is attributable to a mere handful of companies driving the market. |
Bio-IT World
August 2005
Ellen H. Julian |
Tech Expertise Singles Out Outsourcers Biopharmaceutical companies are flocking to consultants, outsourcers, and staffing firms to help with discrete clinical trial processes to gain access to advanced technologies and reduce the drain on already-scarce IT resources. |
Bio-IT World
August 2005 |
News Blast Completes initial closing of financing to support RNAi-based therapies to treat macular degeneration... Mayo Clinic, Translational Genomics Research opens biomedical scientific facility... HistoRx appoints VP of research... Gates Foundation to share grant with 43 project winners... |
| <Older 771-780 Newer> Return to current articles. |
